메뉴 건너뛰기




Volumn 64, Issue 4, 2015, Pages 1262-1272

Role of Epac2A/Rap1 signaling in interplay between incretin and sulfonylurea in insulin secretion

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EPAC2A PROTEIN; GLIBENCLAMIDE; GLICLAZIDE; GLIMEPIRIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INCRETIN; INSULIN; LIRAGLUTIDE; RAP1 PROTEIN; SULFONYLUREA DERIVATIVE; UNCLASSIFIED DRUG; CALCIUM; GUANINE NUCLEOTIDE EXCHANGE FACTOR; RAPGEF4 PROTEIN, MOUSE;

EID: 84928907433     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-0576     Document Type: Article
Times cited : (51)

References (39)
  • 1
    • 33644618433 scopus 로고    scopus 로고
    • The biology of incretin hormones
    • Drucker DJ. The biology of incretin hormones. Cell Metab 2006;3: 153-165
    • (2006) Cell Metab , vol.3 , pp. 153-165
    • Drucker, D.J.1
  • 2
    • 84919685379 scopus 로고    scopus 로고
    • Glutamate acts as a key signal linking glucose metabolism to incretin/cAMP action to amplify insulin secretion
    • Gheni G, Ogura M, Iwasaki M, et al. Glutamate acts as a key signal linking glucose metabolism to incretin/cAMP action to amplify insulin secretion. Cell Reports 2014;9: 661-673
    • (2014) Cell Reports , vol.9 , pp. 661-673
    • Gheni, G.1    Ogura, M.2    Iwasaki, M.3
  • 3
    • 33846006173 scopus 로고    scopus 로고
    • The incretin system: Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
    • Drucker DJ, Nauck MA. The incretin system: Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006;368: 1696-1705
    • (2006) Lancet , vol.368 , pp. 1696-1705
    • Drucker, D.J.1    Nauck, M.A.2
  • 4
    • 0030792753 scopus 로고    scopus 로고
    • Protein kinase A-dependent and -independent stimulation of exocytosis by cAMP in mouse pancreatic B-cells
    • Renström E, Eliasson L, Rorsman P. Protein kinase A-dependent and -independent stimulation of exocytosis by cAMP in mouse pancreatic B-cells. J Physiol 1997;502: 105-118
    • (1997) J Physiol , vol.502 , pp. 105-118
    • Renström, E.1    Eliasson, L.2    Rorsman, P.3
  • 5
    • 0033769693 scopus 로고    scopus 로고
    • CAMP-GEFII is a direct target of cAMP in regulated exocytosis
    • Ozaki N, Shibasaki T, Kashima Y, et al. cAMP-GEFII is a direct target of cAMP in regulated exocytosis. Nat Cell Biol 2000;2: 805-811
    • (2000) Nat Cell Biol , vol.2 , pp. 805-811
    • Ozaki, N.1    Shibasaki, T.2    Kashima, Y.3
  • 6
    • 0035824548 scopus 로고    scopus 로고
    • Critical role of cAMP-GEFII-Rim2 complex in incretin-potentiated insulin secretion
    • Kashima Y, Miki T, Shibasaki T, et al. Critical role of cAMP-GEFII-Rim2 complex in incretin-potentiated insulin secretion. J Biol Chem 2001;276: 46046-46053
    • (2001) J Biol Chem , vol.276 , pp. 46046-46053
    • Kashima, Y.1    Miki, T.2    Shibasaki, T.3
  • 7
    • 64549105338 scopus 로고    scopus 로고
    • Critical role of the N-terminal cyclic AMP-binding domain of Epac2 in its subcellular localization and function
    • Niimura M, Miki T, Shibasaki T, Fujimoto W, Iwanaga T, Seino S. Critical role of the N-terminal cyclic AMP-binding domain of Epac2 in its subcellular localization and function. J Cell Physiol 2009;219: 652-658
    • (2009) J Cell Physiol , vol.219 , pp. 652-658
    • Niimura, M.1    Miki, T.2    Shibasaki, T.3    Fujimoto, W.4    Iwanaga, T.5    Seino, S.6
  • 8
    • 0034759763 scopus 로고    scopus 로고
    • Characterization of the gene EPAC2: Structure, chromosomal localization, tissue expression, and identification of the liver-specific isoform
    • Ueno H, Shibasaki T, Iwanaga T, et al. Characterization of the gene EPAC2: Structure, chromosomal localization, tissue expression, and identification of the liver-specific isoform. Genomics 2001;78: 91-98
    • (2001) Genomics , vol.78 , pp. 91-98
    • Ueno, H.1    Shibasaki, T.2    Iwanaga, T.3
  • 9
    • 37649002935 scopus 로고    scopus 로고
    • Essential role of Epac2/Rap1 signaling in regulation of insulin granule dynamics by cAMP
    • Shibasaki T, Takahashi H, Miki T, et al. Essential role of Epac2/Rap1 signaling in regulation of insulin granule dynamics by cAMP. Proc Natl Acad Sci U S A 2007;104: 19333-19338
    • (2007) Proc Natl Acad Sci U S A , vol.104 , pp. 19333-19338
    • Shibasaki, T.1    Takahashi, H.2    Miki, T.3
  • 11
    • 79957900616 scopus 로고    scopus 로고
    • Dynamics of insulin secretion and the clinical implications for obesity and diabetes
    • Seino S, Shibasaki T, Minami K. Dynamics of insulin secretion and the clinical implications for obesity and diabetes. J Clin Invest 2011;121: 2118-2125
    • (2011) J Clin Invest , vol.121 , pp. 2118-2125
    • Seino, S.1    Shibasaki, T.2    Minami, K.3
  • 12
    • 0033037098 scopus 로고    scopus 로고
    • ATP-sensitive potassium channels: A model of heteromultimeric potassium channel/receptor assemblies
    • Seino S. ATP-sensitive potassium channels: A model of heteromultimeric potassium channel/receptor assemblies. Annu Rev Physiol 1999;61: 337-362
    • (1999) Annu Rev Physiol , vol.61 , pp. 337-362
    • Seino, S.1
  • 13
    • 0033760442 scopus 로고    scopus 로고
    • Triggering and amplifying pathways of regulation of insulin secretion by glucose
    • Henquin JC. Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 2000;49: 1751-1760
    • (2000) Diabetes , vol.49 , pp. 1751-1760
    • Henquin, J.C.1
  • 14
    • 84886590372 scopus 로고    scopus 로고
    • K(ATP) Channels and islet hormone secretion: New insights and controversies
    • Ashcroft FM, Rorsman P. K(ATP) channels and islet hormone secretion: New insights and controversies. Nat Rev Endocrinol 2013;9: 660-669
    • (2013) Nat Rev Endocrinol , vol.9 , pp. 660-669
    • Ashcroft, F.M.1    Rorsman, P.2
  • 15
    • 68149136367 scopus 로고    scopus 로고
    • The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs
    • Zhang CL, Katoh M, Shibasaki T, et al. The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs. Science 2009;325: 607-610
    • (2009) Science , vol.325 , pp. 607-610
    • Zhang, C.L.1    Katoh, M.2    Shibasaki, T.3
  • 16
    • 84886737102 scopus 로고    scopus 로고
    • Antidiabetic sulfonylureas and cAMP cooperatively activate Epac2A
    • Takahashi T, Shibasaki T, Takahashi H, et al. Antidiabetic sulfonylureas and cAMP cooperatively activate Epac2A. Sci Signal 2013;6: Ra94
    • (2013) Sci Signal , vol.6 , pp. ra94
    • Takahashi, T.1    Shibasaki, T.2    Takahashi, H.3
  • 17
    • 62449129181 scopus 로고    scopus 로고
    • Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)
    • LEAD-1 SU study group
    • Marre M, Shaw J, Brändle M, et al.; LEAD-1 SU study group. Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU). Diabet Med 2009;26: 268-278
    • (2009) Diabet Med , vol.26 , pp. 268-278
    • Marre, M.1    Shaw, J.2    Brändle, M.3
  • 18
    • 84871651233 scopus 로고    scopus 로고
    • Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patients
    • Kubota A, Maeda H, Kanamori A, et al. Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patients. J Diabetes Investig 2012;3: 503-509
    • (2012) J Diabetes Investig , vol.3 , pp. 503-509
    • Kubota, A.1    Maeda, H.2    Kanamori, A.3
  • 19
    • 84908569527 scopus 로고    scopus 로고
    • Dipeptidyl peptidase-4 inhibitors and sulfonylureas for type 2 diabetes: Friend or foe?
    • Yabe D, Seino Y. Dipeptidyl peptidase-4 inhibitors and sulfonylureas for type 2 diabetes: Friend or foe? J Diabetes Investig 2014;5: 475-477
    • (2014) J Diabetes Investig , vol.5 , pp. 475-477
    • Yabe, D.1    Seino, Y.2
  • 20
    • 0029799525 scopus 로고    scopus 로고
    • Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas
    • Gutniak MK, Juntti-Berggren L, Hellström PM, Guenifi A, Holst JJ, Efendic S. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas. Diabetes Care 1996;19: 857-863
    • (1996) Diabetes Care , vol.19 , pp. 857-863
    • Gutniak, M.K.1    Juntti-Berggren, L.2    Hellström, P.M.3    Guenifi, A.4    Holst, J.J.5    Efendic, S.6
  • 21
    • 59749096702 scopus 로고    scopus 로고
    • KATP channel closure ameliorates the impaired insulinotropic effect of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes
    • Aaboe K, Knop FK, Vilsboll T, et al. KATP channel closure ameliorates the impaired insulinotropic effect of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes. J Clin Endocrinol Metab 2009;94: 603-608
    • (2009) J Clin Endocrinol Metab , vol.94 , pp. 603-608
    • Aaboe, K.1    Knop, F.K.2    Vilsboll, T.3
  • 22
    • 15944419821 scopus 로고    scopus 로고
    • Distinct effects of glucosedependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility
    • Miki T, Minami K, Shinozaki H, et al. Distinct effects of glucosedependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility. Diabetes 2005;54: 1056-1063
    • (2005) Diabetes , vol.54 , pp. 1056-1063
    • Miki, T.1    Minami, K.2    Shinozaki, H.3
  • 23
    • 79953757245 scopus 로고    scopus 로고
    • Establishment of new clonal pancreatic β-cell lines (MIN6-K) useful for study of incretin/ cyclic adenosine monophosphate signaling
    • Iwasaki M, Minami K, Shibasaki T, Miki T, Miyazaki J, Seino S. Establishment of new clonal pancreatic β-cell lines (MIN6-K) useful for study of incretin/ cyclic adenosine monophosphate signaling. J Diabetes Investig 2010;1: 137-142
    • (2010) J Diabetes Investig , vol.1 , pp. 137-142
    • Iwasaki, M.1    Minami, K.2    Shibasaki, T.3    Miki, T.4    Miyazaki, J.5    Seino, S.6
  • 24
    • 31844447089 scopus 로고    scopus 로고
    • Structure of the cyclic-AMP-responsive exchange factor Epac2 in its auto-inhibited state
    • Rehmann H, Das J, Knipscheer P, Wittinghofer A, Bos JL. Structure of the cyclic-AMP-responsive exchange factor Epac2 in its auto-inhibited state. Nature 2006;439: 625-628
    • (2006) Nature , vol.439 , pp. 625-628
    • Rehmann, H.1    Das, J.2    Knipscheer, P.3    Wittinghofer, A.4    Bos, J.L.5
  • 26
    • 79955961854 scopus 로고    scopus 로고
    • Mechanism of intracellular cAMP sensor Epac2 activation: CAMP-induced conformational changes identified by amide hydrogen/deuterium exchange mass spectrometry (DXMS)
    • Li S, Tsalkova T, White MA, et al. Mechanism of intracellular cAMP sensor Epac2 activation: CAMP-induced conformational changes identified by amide hydrogen/deuterium exchange mass spectrometry (DXMS). J Biol Chem 2011;286: 17889-17897
    • (2011) J Biol Chem , vol.286 , pp. 17889-17897
    • Li, S.1    Tsalkova, T.2    White, M.A.3
  • 27
  • 28
    • 84891698714 scopus 로고    scopus 로고
    • Pancreatic β-cell response to increased metabolic demand and to pharmacologic secretagogues requires EPAC2A
    • Song WJ, Mondal P, Li Y, Lee SE, Hussain MA. Pancreatic β-cell response to increased metabolic demand and to pharmacologic secretagogues requires EPAC2A. Diabetes 2013;62: 2796-2807
    • (2013) Diabetes , vol.62 , pp. 2796-2807
    • Song, W.J.1    Mondal, P.2    Li, Y.3    Lee, S.E.4    Hussain, M.A.5
  • 30
    • 0032545328 scopus 로고    scopus 로고
    • A family of cAMP-binding proteins that directly activate Rap1
    • Kawasaki H, Springett GM, Mochizuki N, et al. A family of cAMP-binding proteins that directly activate Rap1. Science 1998;282: 2275-2279
    • (1998) Science , vol.282 , pp. 2275-2279
    • Kawasaki, H.1    Springett, G.M.2    Mochizuki, N.3
  • 31
    • 77949538387 scopus 로고    scopus 로고
    • Epac: Defining a new mechanism for cAMP action
    • Gloerich M, Bos JL. Epac: Defining a new mechanism for cAMP action. Annu Rev Pharmacol Toxicol 2010;50: 355-375
    • (2010) Annu Rev Pharmacol Toxicol , vol.50 , pp. 355-375
    • Gloerich, M.1    Bos, J.L.2
  • 32
    • 78650090455 scopus 로고    scopus 로고
    • 2+ by glucagon-like peptide-1 receptor agonist exendin-4 is disrupted in β-cells of phospholipase C-e knockout mice
    • 2+ by glucagon-like peptide-1 receptor agonist exendin-4 is disrupted in β-cells of phospholipase C-e knockout mice. J Physiol 2010;588: 4871-4889
    • (2010) J Physiol , vol.588 , pp. 4871-4889
    • Dzhura, I.1    Chepurny, O.G.2    Kelley, G.G.3
  • 33
    • 79955793555 scopus 로고    scopus 로고
    • Phospholipase C-e links Epac2 activation to the potentiation of glucose-stimulated insulin secretion from mouse islets of Langerhans
    • Dzhura I, Chepurny OG, Leech CA, et al. Phospholipase C-e links Epac2 activation to the potentiation of glucose-stimulated insulin secretion from mouse islets of Langerhans. Islets 2011;3: 121-128
    • (2011) Islets , vol.3 , pp. 121-128
    • Dzhura, I.1    Chepurny, O.G.2    Leech, C.A.3
  • 34
    • 77953466435 scopus 로고    scopus 로고
    • Facilitation of β-cell K(ATP) channel sulfonylurea sensitivity by a cAMP analog selective for the cAMP-regulated guanine nucleotide exchange factor Epac
    • Leech CA, Dzhura I, Chepurny OG, Schwede F, Genieser HG, Holz GG. Facilitation of β-cell K(ATP) channel sulfonylurea sensitivity by a cAMP analog selective for the cAMP-regulated guanine nucleotide exchange factor Epac. Islets 2010;2: 72-81
    • (2010) Islets , vol.2 , pp. 72-81
    • Leech, C.A.1    Dzhura, I.2    Chepurny, O.G.3    Schwede, F.4    Genieser, H.G.5    Holz, G.G.6
  • 37
    • 84907044034 scopus 로고    scopus 로고
    • 2+ in female mouse islets stimulated by glucose and tolbutamide
    • 2+ in female mouse islets stimulated by glucose and tolbutamide. Endocrinology 2014;155: 3274-3287
    • (2014) Endocrinology , vol.155 , pp. 3274-3287
    • Henquin, J.C.1    Nenquin, M.2
  • 39
    • 79957904659 scopus 로고    scopus 로고
    • Rim2a determines docking and priming states in insulin granule exocytosis
    • Yasuda T, Shibasaki T, Minami K, et al. Rim2a determines docking and priming states in insulin granule exocytosis. Cell Metab 2010;12: 117-129
    • (2010) Cell Metab , vol.12 , pp. 117-129
    • Yasuda, T.1    Shibasaki, T.2    Minami, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.